FDA approves local biotech's first rare-cancer drug By: Boston Business Journal via Business Journals January 23, 2020 at 18:07 PM EST The FDA has approved the drug Tazverik to treat metastatic or locally advanced epitheliod sarcoma, a rare and aggressive form of soft tissue cancer. Read More >>